Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Blood Cancer Journal|April 26, 2020
A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristicsRicardo Sánchez, Jordi Ribera, Mireia Morgades, et al.
Diagnostic Pathology|April 30, 2025
CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated casesLaura González-Guerrero, Helena Castellet, Clara Martínez, et al.
Stem Cell Reports|May 23, 2017
Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment OutcomesRafael Diaz de la Guardia, Belen Lopez-Millan, Jessie R Lavoie, et al.
Haematologica|February 11, 2010
Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study GroupAlbert Oriol, Susana Vives, Jesús-María Hernández-Rivas, et al.
Blood Cancer Journal|May 5, 2023
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohortGuadalupe Oñate, Marta Pratcorona, Ana Garrido, et al.
Clinical Kidney Journal|August 4, 2026
Drowning the kidneys: from fluid overload to physiology-guided fluid management in onco-hematologyFernando Parra-Londoño, Marina Urrutia-Jou, Jordi Soler-Majoral, et al.
Blood Advances|July 24, 2025
Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AMLPau Montesinos, Dylan M Marchione, Christian Récher, et al.
Genes, Chromosomes & Cancer|August 1, 2017
Copy number profiling of adult relapsed B-cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanismsJordi Ribera, Lurdes Zamora, Mireia Morgades, et al.
Bone Marrow Transplantation|June 1, 2022
Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalanFrancesca Guijarro, Alex Bataller, Marina Diaz-Beyá, et al.
Frontiers in Oncology|December 12, 2022
The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patientsSara Villar, Beñat Ariceta, Xabier Agirre, et al.
Pageof 9